Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy

References

• LencioniRPetruzziPCrocettiLChemoembolization of hepatocellular carcinomaSemin Intervent Radiol20133031124436512
   PubMed Web of Science ®Google Scholar
• ZhouXTangZWangJDoxorubicin-eluting beads versus conventional transarterialchemoembolization for the treatment of hepatocellular carcinoma: a meta-analysisInt J Clin Exp Med201473892390325550897
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver, European Organisation For Research, Treatment of CancerEASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol20125690894322424438
   PubMed Web of Science ®Google Scholar
• HuangKZhouQWangRDoxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinomaJ Gastroenterol Hepatol20142992092524224722
   PubMed Web of Science ®Google Scholar
• NishikawaHKitaRKimuraTTranscatheter arterial embolic therapies for hepatocellular carcinoma: a literature reviewAnticancer Res2014346877688625503113
   PubMed Web of Science ®Google Scholar
• ChengALKangYKChenZEfficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialLancet Oncol200910253419095497
   PubMed Web of Science ®Google Scholar
• XueTCXieXYZhangLTransarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysisBMC Gastroenterol2013136023566041
   PubMed Web of Science ®Google Scholar
• KimHYParkJWJooJSeverity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinomaJ Gastroenterol Hepatol2012271051105622098152
   PubMed Web of Science ®Google Scholar
• ArizumiTUeshimaKChishinaHValidation of the criteria of transcatheter arterial chemoembolization failure or refractoriness in patients with advanced hepatocellular carcinoma proposed by the LCSGJOncology201487Suppl 1323625427731
   PubMed Web of Science ®Google Scholar
• KudoMMatsuiOIzumiNJSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the liver cancer study group of JapanLiver Cancer2014345846826280007
   PubMed Web of Science ®Google Scholar
• RaoulJLGilabertMPianaGHow to define transarterial chemoembolization failure or refractoriness: a European perspectiveLiver Cancer2014311912424945002
   PubMed Web of Science ®Google Scholar
• HuckeFSieghartWPinterMThe ART-strategy: sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACEJ Hepatol20146011812624012941
   PubMed Web of Science ®Google Scholar
• KudoMArizumiTUeshimaKAssessment for retreatment (ART) score for repeated transarterial chemoembolization in patients with hepatocellular carcinomaHepatology2014592424242524114720
   PubMed Web of Science ®Google Scholar
• SieghartWHuckeFPinterMThe ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinomaHepatology2013572261227323316013
   PubMed Web of Science ®Google Scholar
• AdhouteXPenarandaGNaudeSRetreatment with TACE: The ABCR SCORE, an aid to the decision-making processJ Hepatol201562485586225463541
   PubMed Web of Science ®Google Scholar
• AdhouteXPenarandaGRaoulJLRetreatment with TACE: ABCR score and radiological response, a really tight connectionJ Hepatol20156261442144325678389
   PubMed Web of Science ®Google Scholar
• BruixJShermanMLlovetJMClinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the LiverJ Hepatol20013542143011592607
   PubMed Web of Science ®Google Scholar
• LencioniRLlovetJMModified RECIST (mRECIST) assessment for hepatocellular carcinomaSemin Liver Dis201030526020175033
   PubMed Web of Science ®Google Scholar
• ShimJHLeeHCKimSOWhich response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new modelsRadiology201226270871822187634
   PubMed Web of Science ®Google Scholar
• GillmoreRStuartSKirkwoodAEASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolizationJ Hepatol2011551309131621703196
   PubMed Web of Science ®Google Scholar
• DoyonDMouzonAJourdeAMHepatic, arterial embolization in patients with malignant liver tumours (author’s transl)Ann Radiol1974175936034142843
   PubMedGoogle Scholar
• YamadaRNakatsukaHNakamuraKTranscatheter arterial embolization therapy in unresectable hepatomas – experience in 15 casesACTA Hepatol Jpn197920595603
   Google Scholar
• LlovetJMRealMIMontanaXArterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialLancet20023591734173912049862
   PubMed Web of Science ®Google Scholar
• LoCMNganHTsoWKRandomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaHepatology2002351164117111981766
   PubMed Web of Science ®Google Scholar
• LlovetJMBruixJSystematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survivalHepatology20033742944212540794
   PubMed Web of Science ®Google Scholar
• LammerJMalagariKVoglTProspective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V studyCardiovasc Intervent Radiol201033415219908093
   PubMed Web of Science ®Google Scholar
• SaccoRBargelliniIBertiniMConventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinomaJ Vasc Interv Radiol2011221545155221849247
   PubMed Web of Science ®Google Scholar
• RosmorducOHoussetCHypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver diseaseSemin Liver Dis20103025827020665378
   PubMed Web of Science ®Google Scholar
• XiongZPYangSRLiangZYAssociation between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinomaHepatobiliary Pancreat Dis Int2004338639015313674
   PubMedGoogle Scholar
• SchoenleberSJKurtzDMTalwalkarJAPrognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysisBr J Cancer20091001385139219401698
   PubMed Web of Science ®Google Scholar
• ChangYSAdnaneJTrailPASorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft modelsCancer Chemother Pharmacol20075956157417160391
   PubMed Web of Science ®Google Scholar
• KudoMImanakaKChidaNPhase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinomaEur J Cancer2011472117212721664811
   PubMed Web of Science ®Google Scholar
• SansonnoDLaulettaGRussiSTransarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trialOncologist20121735936622334456
   PubMed Web of Science ®Google Scholar
• LencioniRZouJLeberreMSorafenib or placebo in combination with transarterial chemoembolization for intermediatestage hepatocellular carcinoma (SPACE)J Clin Oncol201028 abstr TPS178
   Web of Science ®Google Scholar
• LiuLChenHWangMCombination therapy of sorafenib and TACE for unresectable HCC: a systematic review and meta-analysisPLoS One20149e9112424651044
   PubMed Web of Science ®Google Scholar
• KudoMHanGFinnRSBrivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: a randomized phase III trialHepatology2014601697170724996197
   PubMed Web of Science ®Google Scholar
• HaoMZLinHLChenQEfficacy of transcatheter arterial chemoembolization combined thalidomide on hepatocellular carcinoma: a controlled randomized trialAi Zheng20072686186517697548
   PubMedGoogle Scholar
• ChenJZhouCLongYSunitinib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching studyTumour Biol20153618319125217986
   PubMedGoogle Scholar
• GuLLiuHFanLTreatment outcomes of transcatheter arterial chemoembolization combined with local ablative therapy versus monotherapy in hepatocellular carcinoma: a meta-analysisJ Cancer Res Clin Oncol201414019921024077865
   PubMed Web of Science ®Google Scholar
• KongQFJiaoJBChenQQComparative effectiveness of radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinomaTumour Biol2014352655265924197985
   PubMedGoogle Scholar
• LlovetJMBruixJNovel advancements in the management of hepatocellular carcinoma in 2008J Hepatol200848Suppl 1S20S3718304676
   PubMed Web of Science ®Google Scholar
• ShibataTIsodaHHirokawaYSmall hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?Radiology200925290591319567647
   PubMed Web of Science ®Google Scholar
• YamakadoKNakatsukaAOhmoriSRadiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphologyJ Vasc Interv Radiol2002131225123212471186
   PubMed Web of Science ®Google Scholar
• TakakiHYamakadoKNakatsukaARadiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progressionJ Vasc Interv Radiol20071885686117609444
   PubMed Web of Science ®Google Scholar
• PengZWZhangYJChenMSRadiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trialJ Clin Oncol20133142643223269991
   PubMed Web of Science ®Google Scholar
• ZouLQZhangBLChangQ3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinomaWorld J Gastroenterol201420172271723425493039
   PubMed Web of Science ®Google Scholar
• TseRVHawkinsMLockwoodGPhase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinomaJ Clin Oncol20082665766418172187
   PubMed Web of Science ®Google Scholar
• PriceTRPerkinsSMSandrasegaranKEvaluation of response after stereotactic body radiotherapy for hepatocellular carcinomaCancer20121183191319822025126
   PubMed Web of Science ®Google Scholar
• NishikawaHArimotoAWakasaTEffect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinomaInt J Oncol20134215116023174998
   PubMed Web of Science ®Google Scholar
• YamasakiSHasegawaHKinoshitaHA prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinomaJpn J Cancer Res1996872062118609071
   PubMedGoogle Scholar
• ZhouWPLaiECLiAJA prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinomaAnn Surg200924919520219212170
   PubMed Web of Science ®Google Scholar
• KaiboriMTanigawaNKariyaSA prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinomaDig Dis Sci2012571404141222271410
   PubMed Web of Science ®Google Scholar
• FujikiMAucejoFKimRGeneral overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option?Liver Int2011311081108922008644
   PubMed Web of Science ®Google Scholar
• FrenetteCTOsorioRCStarkJConventional TACE and drug-eluting bead TACE as locoregional therapy before orthotopic liver transplantation: comparison of explant pathologic responseTransplantation20149878178724825513
   PubMed Web of Science ®Google Scholar